Edge Therapeutics Stock Analysis
Technical stock analysis for Wed 12'th Dec 2018
Edge Therapeutics gained 0.08% in the last trading day, rising from $0.46 to $0.46 The price has fallen in 6 of the last 10 days and is down by -12.7% for this period. Volume fell in the last day by -221 250 shares, and in total, 355 234 shares bought and sold for approximately $163 710.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Edge Therapeutics lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $0.38 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -28.86% during the next 3 months and, with 90% probability hold a price between $0.27 and $0.60 at the end of this period.
A buy signal was issued from a pivot bottom point on Tuesday December 11, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Edge Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.50 and $0.65. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSI14 is 30 and the stock is currently not being overbought or oversold
Support & Resistance
Edge Therapeutics finds support from accumulated volume at $0.46.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.03 between high and low, or 6.50%. For the last week the stock has had a daily average volatility of 11.87%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Edge Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|EDGE $0.46 $0.00(0.08%)|
EDGE is up $0.00 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for EDGE based on the 1-3 month system that more than doubles the S&P 500.
Click here – the EDGE analysis is free »